RedHill Biopharma (NASDAQ: RDHL) adjourns AGM after quorum shortfall
Rhea-AI Filing Summary
RedHill Biopharma Ltd. reports that its Annual General Meeting of Shareholders scheduled for August 6, 2026 was adjourned due to a lack of required legal quorum. Under its Amended and Restated Articles of Association, the meeting will reconvene on August 7, 2026 at 3:00 p.m. Israel time at the company’s Tel Aviv offices.
The report is also incorporated by reference into multiple existing registration statements on Forms S-8 and F-3, meaning the disclosed information is now legally part of those previously filed offerings documentation.
Positive
- None.
Negative
- None.
Key Figures
AGM original date: August 6, 2026
AGM reconvened date and time: August 7, 2026, at 3:00 p.m. Israel time
Commission File Number: 001-35773
3 metrics
AGM original date
August 6, 2026
Scheduled date of the Annual General Meeting of Shareholders before adjournment
AGM reconvened date and time
August 7, 2026, at 3:00 p.m. Israel time
Time the Annual General Meeting of Shareholders will reconvene at company offices
Commission File Number
001-35773
SEC commission file number for RedHill Biopharma Ltd.
Key Terms
Report of Foreign Private Issuer, Annual General Meeting of Shareholders, quorum, incorporated by reference, +2 more
6 terms
Report of Foreign Private Issuer regulatory
"FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16"
A report of a foreign private issuer is a formal filing that a non‑U.S. company makes to U.S. regulators to share important business, financial, or governance information with American investors. Think of it as a regular update or press packet that keeps investors informed about events that could change a company’s value—like earnings, management changes, contracts, or regulatory developments—so investors can make timely, informed decisions.
quorum regulatory
"scheduled for August 6, 2026, due to a lack of required legal quorum"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
incorporated by reference regulatory
"This Form 6-K is hereby incorporated by reference into the Company's Registration"
Registration Statements on Form S-8 regulatory
"incorporated by reference into the Company's Registration Statements on Form S-8"
Registration Statements on Form F-3 regulatory
"and its Registration Statements on Form F-3 filed with the Securities"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Why was RedHill Biopharma's (RDHL) Annual General Meeting adjourned?
The meeting was adjourned because the company did not achieve the required legal quorum under its Amended and Restated Articles of Association. Without this quorum, shareholder resolutions cannot be voted on, so the meeting must be held at a later date.
When and where will RDHL's adjourned Annual General Meeting reconvene?
The adjourned Annual General Meeting will reconvene on August 7, 2026 at 3:00 p.m. Israel time at RedHill Biopharma’s offices at 21 Ha'arba’a Street, Tel Aviv. Shareholders may attend on that new date and time.
What is the significance of this RDHL report being incorporated by reference into its registration statements?
Incorporation by reference means the information in this report is now legally part of RedHill’s existing Forms S-8 and F-3. Investors relying on those registration statements must consider this report as included in the offering disclosures.
What type of SEC report did RedHill Biopharma (RDHL) file and for which period?
RedHill Biopharma filed a Form 6-K Report of Foreign Private Issuer for the month of August 2026. This form allows foreign private issuers to furnish current information to U.S. investors between annual reports.